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Department of Respirafovy Medicine, University Hospital, Aarhus, Denmark 
The aim of this study was to investigate the predictive value of peripheral eosinophil and monocyte blood counts 
regarding lung function in smokers and non-smokers, and to investigate the influence of smoking on these cell 
counts. 
Forced expiratory volume in 1 s (FEV,) measurements and blood samples were collected from 298 non-atopic 
smokers and 136 never-smokers. Blood samples were repeated in 160 smokers after cessation of smoking (quitters) 
and 30 continuing smokers, 2, 6, 12 and 26 weeks after smoking cessation. 
Monocyte (WO.05) but not eosinophil blood counts were higher in never-smokers compared to smokers. In 
never-smokers, blood eosinophil counts and monocyte counts correlated inversely (PcO.05) and directly (P<O.Ol), 
respectively, with standardized FEV, residuals (FEVR). In smokers, blood eosinophil (WO.05) and monocyte 
(PcO.05) counts correlated directly with FEVR independent of smoking history. After smoking cessation, monocyte 
blood counts (PcO.05) increased. Both eosinophil and monocyte blood counts showed a greater increase in quitters 
with decreased lung function (PcO.05). Former heavy smokers had higher blood eosinophil (PcO.05) but lower 
monocyte (PcO.05) count increase than had former light smokers. 
These data suggest that smoking influences eosinophil and monocyte blood counts and that this is associated with 
a small negative effect on lung function. Eosinophil blood counts had an opposite relation to lung function in 
smokers and non-smokers. Further research should include investigations of relations between smoking and 
stimulatory factors for recruitment and activity of eosinophils and monocytes. 
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Introduction 
Smoking is an important factor in increased loss of lung 
function (l), but the mechanisms are, to a wide extent, 
unknown. The eosinophil granulocyte has been associated 
with lung damage (24) and it is an important effecter cell in 
asthma (5-g). Similar levels of blood eosinophils in smokers 
and never-smokers have been found in some studies (9-12). 
One study suggested a disproportionate increase in total 
blood eosinophils in smokers compared to other blood 
white cells, but an unaffected eosinophil percentage (10). 
The blood eosinophil count was inversely related to lung 
function in non-smokers (10,ll) whereas no such relation 
was found in smokers (10,11,13). A weak and non- 
significant relation between actual cigarette consumption 
and blood eosinophil counts has been reported, but the 
population had not been tested for atopy (11). The relation- 
ship between eosinophil blood counts, smoking and 
lung function therefore needs clarification in a non-atopic 
population. 
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Monocytes are precursors of alveolar macrophages, 
which play an important role in the immune function of the 
lungs. It has been suggested that the percentage of mono- 
cytes in the differential white blood cell count is elevated in 
smokers compared to non-smokers (14,15). Smokers’ 
monocytes have a relative defective microbicidal function 
(15), and the ability to release elastase-like compounds (17). 
Furthermore, blood monocytes and alveolar macrophages 
are primed for release of oxygen radicals in smokers (16). 
Smoking-induced functional changes of blood monocytes, 
therefore, may be of pathogenetic importance in the devel- 
opment of smoking-induced impairment of lung function. 
The aim of this study was to investigate possible relation- 
ships between eosinophil and monocyte blood counts and 
lung function, and smoking history in a sample of non- 
atopic smokers and never-smokers. The validity of these 
relationships tested by repeated measurement of the blood 
counts of eosinophils and monocytes in 160 ex-smokers 
who managed to stay abstinent for 6 months. 
Materials and Methods 
Four hundred and ninety-eight smokers volunteered to 
participate in a smoking cessation programme and were 
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TABLE 1. Demographic details 
Smokers Non-smokers 
n 298 136 
Age (years) 43.5 + 12.2 45.7 f 13.11 
Gender (m/f) 1461153 65172 
Industrial/office workers 991199 56180 
Smoking duration (years) 22.6 5 7.5 
Daily tobacco consumption* 
(cigarettes per day) 21.9 & 8.5 
Packyears consumption* 25.4 f 14.4 
Cigarette smokers 229 
Mean * S.D. is given for continuous variables. Smokers and non-smokers were comparable with 
respect to all relevant variables. 
*See text for definition. 
TABLE 2. Demographic variables for 160 ex-smokers (quitters) and 30 continuing smokers 
Age (years) 
Gender (m/f) 
Smoking duration (years) 
Packyears 
Daily cigarette consumption 
NS, not significant. 
Quitters 
(n=160) 
43+13 
77183 
21.6 f 11.1 
25.4zt 18.5 
22.7 f 11.1 
Continuing smokers 
(n=30) 
43* 11 
17113 
23.1 f 9.6 
28.1 f 17.6 
24.1 f 12.2 
P 
NS 
NS 
NS 
NS 
NS 
followed for 6 months. The smoking population was 
recruited through the press. The non-smoking control 
group (n= 163) was recruited through requests to randomly 
chosen local industrial plants and municipal offices. 
The study population consisted of 298 smokers and 136 
never-smokers who had no history or clinical evidence of 
allergy, asthma or infectious disease within the last 14 days, 
had reproducible lung function tests, and used no oral or 
inhaled steroids. Their demographic data are presented in 
Table 1. 
The variation in total eosinophil and monocyte blood 
counts and percentages of the differential white cell blood 
count after the cessation of smoking was studied in 160 
ex-smokers, who remained abstinent for 6 months (quitters), 
and in 30 smokers who chose to continue smoking (continu- 
ing smokers). Continuing smokers were used as a smoking 
reference group. Quitters and continuing smokers had com- 
parable age, smoking history and sex distribution (Table 2). 
Forced expiratory volume in 1 s (FEV,) and forced vital 
capacity (FVC) was measured using a dry spirometer 
(Vitalograph Ltd, Buckingham, U.K.) before the start of 
the trial. The best of three reproducible measurements with 
less than 5% variation was recorded. Normal values for 
FEV, and FVC were taken from the European Working 
Party of Standardization of Lung Function Tests (18). 
All participants underwent an allergological examination 
with skin prick test (SPT) (Soluprick, ALK-Laboratories, 
Copenhagen, Denmark) and allergen-specific IgE analyses 
(phadebas RAST, Pharmacia Diagnostics, Uppsala, 
Sweden). The 14 allergens included detect more than 95% 
of IgE allergies in Denmark. Subjects with a positive skin 
test or with a RAST 2 0.35 ku l- ’ were excluded. 
The smoking history was recorded with respect to 
duration of smoking (years), type of tobacco smoked 
(pipe tobacco, cigarettes, small cigars and cigars) and name 
of the brand smoked. Pipe and cigar tobacco was converted 
into corresponding numbers of cigarettes. One gram of 
pipe tobacco= 1 cigarette, 1 small cigar=3 cigarettes, and 
1 cigar=4 cigarettes. Daily cigarette consumption (DC) 
was the daily consumption of tobacco converted into 
cigarettes. Packyears consumption (PC) was defined for all 
smokers as duration of smoking multiplied by the number 
of cigarettes smoked per day and divided by 20. Tobacco 
abstinence was controlled by measuring the concentration 
of CO in expired air (Ecolyzer CO-monitor, Hawthorne, 
NY, U.S.A.) (19). 
Blood leucocyte counts were measured with a Coulter 
counter S (Coulter Electronics, Hialeah, FL, U.S.A.) and 
blood differential counts were determined by counting 200 
cells in a smear stained with May-Grunewald-Giemsa 
solution. Total blood eosnophil (TEOS) and monocyte 
(TMON) counts were calculated by multiplying the differ- 
ential eosinophil (EOS%) and monocyte (MON%) counts, 
respectively, by the total leucocyte count. 
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The total cell numbers measured in this way were com- 
pared with the numbers measured on a Coulter-STKS 
machine. The correlation coefficients for eosnophils and 
monocytes were 0.8 and 0.51, respectively. The eosinophil 
and monocyte percentages of the differential while blood 
cell count estimated through conventional differential white 
blood cell count performed by the authors’ laboratory was 
compared with the estimates of the central laboratory of 
Aarhus University Hospital, The correlation coefficient 
between the two estimates was 0.9 for eosinophils 
(P<O,OOOl) and 0.8 for monocytes (P<O.OOOl). 
After smoking cessation, DTEOS, DTMON, DEOS% 
and DMON% were defined as the differences from baseline 
in TEOS, TMON, EUS% and MONO/o, respectively, at 
weeks 2, 6, 12 and 26 in 160 quitters who managed to stay 
abstinent for 26 weeks and in 30 continuing smokers. FEV, 
and daily cigarette consumption (DC) were tested for 
association with DETEOS, DTMON, DEOS% and 
DMON% at the time points after smoking cessation at 
which the respective variables reached the highest signifi- 
cance. In these analyses were included all participants who 
were still abstinent at the time. For eosinophils at 6 weeks, 
rz=234, and for monocytes at 12 weeks n=206. 
Ethics 
All participants gave their informed consent to participate. 
The study had the approval of the Ethics Committee of 
Aarhus county. 
Statistics 
The BMDP statistical software package (20 was employed 
in all calculations. Comparisons of demographic details 
between groups were performed with Pearsons chi-square 
and Student’s t-test. Student’s t-test was used for compari- 
sons of group means, and the paired t-test along with tests 
for repeated measures were used to evaluate variations in 
eosinophil and monocyte blood counts after smoking 
cessation. The technique of standardized residuals of FEV, 
and FVC was used to evaluate lung functions (21). A 
Gaussian distribution of eosinophil and monocyte blood 
counts was accomplished by logarithmic transformation, 
Values are given as geometric means & (Q3 - Ql/2), where 
Ql and Q3 are the 25th and 75th quartile of the distribu- 
tion, respectively. P values less than 5% were considered 
significant and P values between 5 and 10% were considered 
to represent a trend. 
Results 
Total blood eosinophils (TEOS), total blood monocytes 
(TMON), eosinophil percentage (EOS%) and monocyte 
percentages (MON%) were independent of sex and age. 
Eosinophil and monocyte blood counts did not correlate 
significantly in non-smokers and smokers before and after 
smoking cessation. 
The geometric mean i (Q3 - Q1)/2 (GMEAN) (TEOS) 
in smokers (n=298) was (88.6 i 104) x lo6 1~ ’ and in non- 
smokers (n= 136) was (108 + 95) x lo6 1~ i (not significant). 
In smokers and non-smokers, GMEAN (TMON) was 
(162 5 132) x lo6 1-i and (218 f 92) x lo6 l-i, respectively 
(PcO.05). 
TEOS correlated in non-smokers inversely with the 
standardized FEVR ly=x x (1.3 f 0.06)+1.1; P<O.O5]. 
TEOS accounted for 4% of the variation in FEVR. 
TMON correlated directly with FEVR 
Cy=x x (0.3 i 0.13) - 0.45; P<O.O5]. TMON accounted for 
4.5% of the variation in FEVR. In a multiple linear 
regression analysis, TEOS and TMON were linear and 
independent of each other related to FEVR (P<O.Ol), and 
accounted together for 8% of the variation in FEVR in 
non-smokers. 
The smokers were grouped into four groups: I, DC<20 
and FEVR within 95% confidence intervals (CI) (n=l13); 
II, DC 120 and FEVR decreased more than 2 S.D. (II= 15); 
III, DC >20 and FEVR within 95% CI (n= 140; and IV, DC 
>20 and FEVR decreased more than 2 S.D. (n=30). 
GMEANS (TEOS) per litre in groups I-IV were 
(119 & 113) x 106, (30 f 60) x 106, (80 f 93) x lo6 and 
(132 & 188) x 106, respectively. TEOS was higher in 
smokers with FEVR within 95% CI compared to smokers 
with FEVR decreased more than 2 S.D. independent of DC 
(P>O.Ol), and tended to be higher in smokers with DC 120 
compared to smokers with higher DC (0.05<P<O.l) 
independent from FEVR (Fig. 1). In a linear regression 
analysis, In (TEOS) correlated with FEVR Cy=x x (1.3 i 
0.06) - 0.9; P<O.O5] and explained 1.5% of the variation in 
FEVR. 
GMEANS (TMON) per litre in groups I-IV were 
(146 + 135) x 106, (87 + 89) x 106, (218 f 125) x lo6 and 
(132 f 188) x 106, respectively (Fig. 1). TMON was higher 
in smokers with FEVR within 95% CI compared to smok- 
ers with FEVR decreased more than 2 S.D. independent of 
DC (WO.01) and tended to be higher in smokers with DC 
greater than 20 compared to smokers with a lower DC 
independent of FEVR (0.05<P<O.l) (Fig. 1). Ln (TMON) 
correlated in a linear regression analysis with FEVR 
ly+x x (0.15iO.O7)- 1.1; BO.051 in which 1.5% of the 
variation was explained. 
Daily cigarette consumption (DC) correlated inversely 
with FEVR (P<O.O5). 
In a multiple linear regression, DC, TEOS and TMON 
correlated with FEVR (P<O.O05); and together they 
accounted for 5% of the variation in FEVR and DC; TEOS 
and TMON kept their individual significance. 
VARIATION IN TEOS AND TMON AFTER 
SMOKING CESSATION 
Values for mean X! S.E.M. DTEOS and DTMON are shown 
in Table 3 and Fig. 2. Repeated measure variance analyses 
showed an increase with time over the first 6 months for 
DTMON (P<O.O5), and a tendency of an increase for 
DTEOS (0.05<P<O.l) in quitters, while no change was seen 
in continuing smokers. 
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FIG. 1. Total eosinophil and monocyte blood counts in 298 smokers grouped according to daily cigarette consumption 
(DC) and standardized FEV, residuals (FEVR). FEVR < - 2 S.D. means FEVR decreased more than 2 S.D. FEVR > - 2 
S.D. means FEVR greater than the lower 95% confidence limit. Bars represent geometric means and vertical lines Q,-Q,/2. 
Qr and Q3 are the first and third quartiles, respectively. Cross-hatched bars, total eosinophil blood count; solid bars, total 
monocyte blood count. Total eosinophil blood counts were higher in smokers with FEVR greater than the lower 95% 
confidence limit compared to smokers with FEVR decreased more than 2 S.D. (n=45) (PcO.01) independent of DC, and 
tended to be higher in smokers with DC<20 (n= 128) compared to smokers with larger DC (0.05<P<O.l) independent of 
FEVR. Total monocyte counts were higher in smokers with FEVR greater than the lower 95% confidence limit (n=253) 
compared to smokers with FEVR decreased more than 2 S.D. independent from DC (PcO.01) and tended to be higher in 
smokers with DC greater than 20 (n= 170) compared to smokers with a less consumption (0.05<P<20.1) independent of 
FEVR. For definition of DC, see the text. 
TABLE 3. Difference from baseline at weeks 2, 6, 12 and 26 after smoking cessation in the eosinophil 
and monocyte total blood counts in 160 quitters and 30 continuing smokers 
Week 2 Week 6 Week 12 Week 26 
Total eosinophil blood counts per litre (*106) 
Quitters 100 + 90 30 5 20” 2* 17 20% 18 
Continuing smokers - 20 f 40 - 50 * 30 - 30 + 50 -40*50 
Difference NS P<O.Ol NS NS 
Total monocyte blood counts per litre (*106) 
Quitters 110+3ot 40 Ek 20* 90 * 201 l&18 
Continuing smokers - 34 It 28 - 28 zt 29 - 37 $: 29 5.6 z!z 40 
Difference P<O.O05 0.05<P<O.l PCO.005 NS 
Values are given as mean i S.E.M. NS, not significant. 
*Different from baseline with P<O.O5. 
TDifferent from baseline with P<O.OOl. 
$Different from baseline with P<O.OOOl. 
At 6 weeks, FEVR correlated inversely (PcO.05) and 
DC directly (PcO.05) with DTEOS, and DC and FEVR 
together and independent of each other accounts for 4% 
of the variation in DTEOS (P<O.Ol). 
After 6 weeks, DTEOS (PcO.05) and DTMON (PcO.05) 
were independently related to FEVR and together they 
explained 7% of the variation in FEVR. 
At 12 weeks, mean Z!Z S.D. DTMON in quitters with DC 
520 (n=92) was (134 f 230) x lo6 l- ‘, and in quitters with 
larger consumption, (61 + 237) x lo6 1-r (PcO.05). FEVR 
correlated inversely with DTMON, and explained 4% of the 
variation in DTMON (P<O.Ol). DC and FEVR together 
accounted for 4.5% of the variation in DTMON (PcO.01). 
EOSINOPHIL AND MONOCYTE PERCENTAGES 
All the above calculations were repeated for eosinphil and 
monocyte percentages. The results were very similar, and 
minor differences are taken up in the Discussion. 
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FIG. 2. Difference from baseline at weeks 2, 6, 12 and 26 after smoking cessation of total eosinophil and monocyte blood 
counts in 160 quitters staying abstinent for 6 months and in 30 continuing smokers. Bars represent means and vertical 
lines represent 1 S.E.M. D-total cell counts is the difference from baseline in total eosinophil and monocyte cell counts as 
indicated. Cross-hatched bars, quitters; solid bars, 30 continuing smokers (controls). Difference from baseline: *P<O.O5; 
tP~0.01; $P<O.O05; $P<O.OOl. Difference between ex-smokers and smokers: **0~05<P~0~1; ‘rtPco.05; $$P<O.Ol; 
&P~O~OO5. 
NICOTINE SUBSTITUTION 
The development in DEOS%, DMON%, DTEOS and 
DTMON was compared between quitters who received 
nicotine chewing gum during the first 12 weeks after 
smoking cessation (n=88) and the rest of the population, 
but no difference was found between the groups. 
Discussion 
The aim of this study was to look for associations between 
eosinophil and monocyte blood counts, lung function and 
smoking. In never-smokers, high eosinophil and monocyte 
counts were associated with decreased lung function. Smok- 
ing was associated with lower monocyte blood counts 
compared to non-smokers. For eosinophil counts, no sig- 
nificant differences were found regarding smokers and 
non-smokers, but heavy smokers had lower counts than 
light smokers. Monocyte counts were higher in heavy 
smokers compared to light smokers. Both eosinophil and 
monocyte counts were directly related to lung function in 
smokers. 
The population in this study were non-atopic, used no 
medication, and had no other illness that could affect 
eosinophil and monocyte counts or lung function. 
Eosinophil and monocyte blood counts are - due to their 
small proportions of the differential blood cell count - 
imprecise measurements. The present counts of 200 cells 
showed acceptable agreement with the counts of a Coulter- 
STKS machine regarding eosinophils, but the agreement 
was rather poor regarding monocytes, and this applied to 
both the authors’ laboratory and the central laboratory of 
the University Hospital (unpubl. results). However, the 
estimation of eosinphil and monocyte percentages of the 
differential white blood cell count at the authors’ laboratory 
and the central laboratory of Aarhus University Hospital 
agreed acceptably. 
Repeated measurement analysis of variance was 
employed to detect changes in the blood counts after 
smoking cessation in 160 quitters. This method of analysis 
did not reveal any relations between the differences in 
eosinophil and monocyte blood counts and lung function 
and magnitude of cigarette consumption. Reasons for this 
might be a combination of large variances of the variables, 
and too few persons with decreased lung function. To 
reveal differences in the development in eosinophil and 
monocyte blood counts in quitters regarding lung function 
and cigarette consumption, the authors performed analyses 
of the development at the time points after the smoking 
cessation where the difference from baseline for the eosino- 
phi1 and monocyte blood counts reached the highest signifi- 
cance. Conclusions made on this basis are not as strong as 
if they had been drawn from the repeated measurement 
variance analyses directly, but do, however, give a valid 
background for the authors’ conclusions. 
Although the repeated measure variance analysis sug- 
gested an increase from baseline with time after smoking 
cessation in eosinophil and monocyte cell numbers, the 
differences after 6 months were not significantly different 
from baseline. This could be caused by simultaneous and 
inverse changes in other cell types. However, the differences 
in the percentages of the differential cell counts from 
baseline (data not presented) remained constant throughout 
the observation time, and the differences from baseline in 
eosinophil and monocyte cell numbers were independently 
related to lung function. This would not be possible if a 
common confounder had caused the relations. It is con- 
cluded that the observed differences in eosinophil and 
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monocyte cells numbers from baseline and relations to lung 
function were not significantly influenced by changes in 
other cell types. 
Earlier studies on differences in eosinophil blood counts 
between smokers and non-smokers have largely agreed 
about higher counts in smokers (9-l 1,13,14). The present 
study found no difference in the eosinophil blood count 
between smokers and non-smokers, even when examining 
the development in the blood counts after the cessation of 
smoking, except for an insignificant trend. However, as 
heavy smokers had lower counts than light smokers, some 
negative influence from smoking on the eosinophil counts 
was suggested. 
In non-smokers, the association between high eosinophil 
blood counts and decreased lung function was confirmed 
(9,11,13). Studies on associations between eosinophil blood 
counts or sputum eosinophilia and lung function in smok- 
ers have given conflicting results (9,10,22). In the present 
study, the inverse relationship between the magnitude of the 
difference in eosinophil blood counts after smoking cessa- 
tion and lung function supported the validity of the present 
observation of better lung function preservation in non- 
atopic smokers with high eosinophil blood counts. The 
activity of blood eosinophils, however, seems to be a more 
important factor as differences in serum eosinophil cation 
protein explained more than 6% of the variation in FEVR 
(23) whereas differences in blood eosinophil counts only 
accounted for about 2% of the variation. The weak but 
significant association between blood eosinophil counts and 
lung function allows no prediction of the risk of an 
increased lung function deterioration in smokers by these 
parameters. The results, however, suggested different re- 
lations between eosinophil blood counts and lung function 
in smokers and non-smokers. As both activity and (prob- 
ably) counts of the blood eosinophils are affected by 
smoking, it is possible that the responsible mechanisms 
were to be found in an action of tobacco smoke on factors 
which stimulate formation and activity of blood eosinophils 
(24,25). No evidence that nicotine itself should be the 
responsible factor was found. Earlier studies on blood 
monocyte counts in smokers have been fairly consistent in 
reporting an increased monocyte blood count compared to 
non-smokers (26,14,15), while no change in the monocyte 
percentage was noted (14). 
The negative influence of smoking on blood monocyte 
counts was supported by the increased counts after the 
cessation of smoking. The discrepancy to other studies 
might be due to differences in the populations’ smoking 
histories, but unfortunately such information is not 
available. In addition, smoking habits have changed 
towards brands with a lower content of nicotine and 
tar, which would also tend to give lower counts in studies 
today. 
To the authors’ knowledge, no other studies have related 
lung function and monocyte blood counts. In this study, 
preservation of lung function in smokers and non-smokers 
was best if monocyte counts were high. This was confirmed 
in smokers, as monocyte counts increased more in quitters 
with decreased lung function compared to quitters with 
normal lung function. A sufficient number of monocytes 
therefore seems to be more important for lung function 
preservation than does the possible monocytelmicrophage 
dysfunction induced by smoking (15), ability of releasing 
oxygen radicals (16) or ability of releasing elastase-like 
compounds (17). Blood monocyte counts accounted, at 
most, for 2.5% of the variation in FEVR. Therefore, their 
value as predictors of increased lung function loss in 
smokers was limited. 
The results of this study showed that smoking not only 
affects the humoral immune system (27) but also the 
cellular immune system, as the number of monocytes and 
possibly also eosinophils was decreased due to smoking. 
The responsible mechanisms might be a depressive influence 
of smoking on stimulative factors for eosinophil and mono- 
cyte production and activation, such as smoking’s impair- 
ment of lymphocyte function by reducing the amount of 
IL-l released from macrophages (28). 
The study was essentially cross-sectional, although it 
contained prospective elements. The questions regarding 
the influence of smoking on blood eosinophils and mono- 
cytes and their influence on lung function should be 
re-investigated in a prospective study, and should possibly 
include studies of tobacco smoke’s influence on cytokines 
that regulate the production and activity of eosinophils and 
monocytes. 
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